Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease

This study has been completed.
Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Mycoses
2		Additional conditions recognized in this trial
			Granulomatous Disease, Chronic
3		More general conditions related to this trial
			Genetic Diseases, Inborn
			Genetic Diseases, X-Linked
			Hematologic Diseases
			Immune System Diseases
			Immunologic Deficiency Syndromes
			Leukocyte Disorders
			Phagocyte Bactericidal Dysfunction
4		Interventions listed in this trial
			itraconazole
5		Additional drug interventions recognized in this trial
			Hydroxyitraconazole
6		More general drug interventions related to this trial
			Anti-Infective Agents
			Antifungal Agents
			Antiparasitic Agents
			Antiprotozoal Agents
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Allergy and Infectious Diseases (NIAID)